Whether investigating collagen-related pathways, skin appearance research, hair follicle studies, or broader regenerative science applications, GHK-CU remains one of the most established peptides in this category
If BPC-157 was purchased today, the patent would likely expire in 2033 before the phase 1-2-3 trials would be completed, at which point all the generic manufacturers would be able to push the product on the back of all the hard work a pharmaceutical company can do (Im not sure if FDA approval would push the expiration of the patent back, but even then it would not be so financial lucrative)
Another 2020 publication, The Compromised Intestinal Barrier Induced by Mycotoxins, is a comprehensive review of research linking mycotoxin-induced intestinal damage
This displaced material may press against nearby nerve roots, causing the characteristic pain, numbness, and weakness associated with disc problems
Wu Q, Maniatis T